substituent effects,6 SAM analogue7 and KIE studies,8
inductively coupled plasma-atomic emission spectrometry
analysis (ICP-AES),9 and X-ray crystallographic data.
Despite this progress, the facial selectivity of cyclopropa-
nation (methylenation) as it occurs in E. coli has not been
elucidated. Because cyclopropanation is catalyzed by a single
gene product in this organism, the enantioselectivity of initial
methyl transfer can be probed by determining the absolute
configuration of the two major cyclopropane fatty acids
found in E. coli lipids. Herein, we report on the results of
our stereochemical analysis.
fatty acid methyl ester did not affect the subsequent stere-
1
ochemical analysis. The diagnostic GC-MS, H NMR, and
5
13
C NMR data of biosynthetic 2 matched those of an
authentic standard in all respects (see Supporting Informa-
tion).
Quasisymmetrical cyclopropyl fatty acids such as 1 and 2
are only weakly optically active, which renders comparison
1
9-21
with chiral reference standards
problematic. However,
long-chain cyclopropyl fatty acids are readily oxidized to a
pair of separable, regioisomeric, keto derivatives and these
compounds can be easily correlated with the appropriate
reference compounds on the basis of their distinctive
The lipid fraction (1 g) of E. coli B-ATCC 11303 (Avanti
Polar Lipids, Inc., Alabaster, Alabama) was hydrolyzed
2
2
chiroptical properties. Thus, mild CrO
mg) yielded ketones 4 (7.9 mg, R ) 0.08, [SiO
Et O (10:1)]) and 5 (6.2 mg, R ) 0.11); in a similar manner,
6 (8.0 mg, R ) 0.11) and 7 (4.4 mg, R ) 0.13) were
3
oxidation of 1 (72
f
2
, Hexane/
(
refluxing 2 N KOH, 50% ethanol), and the free fatty acids
were isolated and methylated (BF /MeOH) essentially as
previously described.16 The fatty acid methyl ester fraction
FAME, 729 mg) was analyzed by GC-MS; the presence of
2
f
3
f
f
obtained from 2 (112 mg) (see Figure 1). The keto derivatives
(
two cyclopropyl fatty acids, methyl 9,10-methanohexade-
canoate 1 (20%) and its C-19 homologue commonly known
as methyl lactobacillate 2 (12%), was detected. The remain-
ing FAMEs were identified as methyl tetradecanoate (1%),
methyl hexadecanoate (36%), methyl octadecanoate (1%),
methyl (Z)-11-octadecenoate (28%), and methyl (Z)-9-
hexadecenoate (2%). This profile is typical of E. coli
17
FAME. The identity of each analyte was initially confirmed
through a comparison of retention time and mass spectral
characteristics of authentic standards. (Synthetic cyclopropyl
fatty acid methyl esters 1 and 2 were prepared from the
corresponding, commercially available, olefinic precursors
18
by a modified Simmons-Smith reaction. ) To isolate each
individual biosynthetic cyclopropyl fatty acid, the E. coli lipid
extract was chromatographed using reversed-phase HPLC
(
Whatman Partisil Magnum 9 10/50 ODS-2 column, 25%
EtOAc/ACN), and fractions enriched in 1 (238 mg) and 2
112 mg) were obtained from a total of 70 chromatographic
runs. Crude 1 was treated with meta-chloroperbenzoic acid
55% pure, 165 mg, 0.5 mmol) to convert coeluting olefinic
fatty acids to the more polar epoxides which were subse-
quently removed by flash chromatography (SiO , 10%
Figure 1. Comparison of [Φ] values obtained for ketones 4-7
D
(
derived from biosynthetic 1 and 2 with synthetic standards 8 and
22
9.
(
were separated by flash chromatography (SiO
2 2
, Hexane/Et O
2
[
10:1]) and identified on the basis of diagnostic mass spectral
EtOAc/hexanes). In this manner, 72 mg of purified biosyn-
fragmentation patterns which are typical for this class of
compounds. All analytical data (R
NMR, and C NMR data) matched those for authentic
standards obtained upon oxidation of synthetic 1 and 2 (see
Supporting Information). The optical rotation of each ketone
1
thetic 1 was obtained as a colorless oil; the GC-MS, H
22
1
f
values and MS, H
1
3
NMR, and C NMR data of this material correlated well
with those of a synthetic reference standard (see Supporting
Information). Crude 2 was not purified further to remove
methyl hexadecanoate because the presence of this saturated
13
21
21
was obtained (4, [R]
25.7 (c 0.62, Et O); 6, [R]
) +24.9 (c 0.44, Et
molecular rotations [Φ] were compared to the values
D
) -20.1 (c 0.70, Et
2
O); 5 [R]
) -17.4 (c 0.62, Et
2
O)), and the corresponding
D
)
2
1
+
[
2
D
2
O); 7
(
8) Iwig, D. F.; Grippe, A. T.; McIntyre, T. A.; Booker, S. J. Biochemistry
004, 43, 13510.
9) Courtois, F.; Guerard, C.; Thomas, X.; Ploux, O. Eur. J. Biochem.
004, 271, 4769.
10) Iwig, D. F.; Uchida, A.; Stromberg, J. A.; Booker, S. J. J. Am. Chem.
Soc. 2005, 127, 11612.
21
R]
D
2
2
D
(
2
2
obtained by Tocanne for related compounds 8 and 9, as
displayed in Figure 1.
(
(
(
(
(
(
11) Courtois, F.; Ploux, O. Biochemistry 2005, 44, 13583.
12) Lederer, E. Q. ReV. Chem. Soc. 1969, 23, 453.
13) Buist, P. H.; Maclean, D. B. Can. J. Chem. 1982, 60, 371.
14) Arigoni, D. Chimia 1987, 41, 9.
(19) Kobayashi, S.; Tokunoh, R.; Shibasaki, M.; Shinagawa, R.; Mu-
rakami-Murofushi, K. Tetrahedron Lett. 1993, 34, 4047. Note that the
specific rotations reported for the two enantiomers of synthetic 1 reported
in this paper are reversed in sign compared to those determined for analogous
enantiomer(s) of synthetic 220 and synthetic 3.
15) Cohen, T.; Herman, G.; Chapman, T. M.; Kuhn, D. J. Am. Chem.
21
Soc. 1974, 96, 5627.
(
(
16) Buist, P. H.; Behrouzian, B. J. Am. Chem. Soc. 1998, 120, 871.
17) Law, J. H.; Zalkin, H.; Kaneshiro, T. Biochim. Biophys. Acta 1963,
(20) Coxon, G. D.; Al-Dulayymi, J. R.; Baird, M. S.; Knobl, S.; Roberts,
E.; Minnikin, D. E. Tetrahedron: Asymmetry 2003, 14, 1211.
(21) Lou, L.; Horikawa, M.; Kloster, R. A.; Hawryluk, N. A.; Corey, E.
J. J. Am. Chem. Soc. 2004, 126, 8916.
7
0, 143.
18) Imai, N.; Sakamoto, K.; Takahashi, H.; Kobayashi, S. Tetrahedron
Lett. 1994, 35, 7045.
(
(22) Tocanne, J. F. Tetrahedron 1972, 28, 363.
80
Org. Lett., Vol. 8, No. 1, 2006